Who has invested in Alladapt Immunotherapeutics?

Enavate Sciences, Gurnet Point Capital, Allerfund, Novartis, Red Tree Venture Capital, WestRiver Group are named among the investors backing Alladapt Immunotherapeutics.

Alladapt Immunotherapeutics Funding: $179M Raised, Series C

Alladapt Immunotherapeutics funding overview

Alladapt Immunotherapeutics is based in Menlo Park, California. Alladapt Immunotherapeutics has raised $179M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series C announced in June 2022. The round record for Alladapt Immunotherapeutics runs through 2022; nothing later has been disclosed. Investors on record include Enavate Sciences, Gurnet Point Capital, Allerfund, Novartis, Red Tree Venture Capital, WestRiver Group. 6 distinct backers are named across the disclosed rounds.

Alladapt Immunotherapeutics at a glance

Total raised: $179M
Latest round: Series C
Latest round date: June 2022
Headquarters: Menlo Park, California
Notable investors: Enavate Sciences, Gurnet Point Capital, Allerfund, Novartis, Red Tree Venture Capital, WestRiver Group

Frequently asked about Alladapt Immunotherapeutics funding

How much has Alladapt Immunotherapeutics raised?: Alladapt Immunotherapeutics has raised $179M in total disclosed funding across the rounds on record.
Who has invested in Alladapt Immunotherapeutics?: Enavate Sciences, Gurnet Point Capital, Allerfund, Novartis, Red Tree Venture Capital, WestRiver Group are named among the investors backing Alladapt Immunotherapeutics.
What was the latest Alladapt Immunotherapeutics funding round?: The most recent disclosed round is a Series C, announced in June 2022.
Where is Alladapt Immunotherapeutics based?: Alladapt Immunotherapeutics is based in Menlo Park, California.
When did Alladapt Immunotherapeutics last raise?: The last disclosed Alladapt Immunotherapeutics round closed in June 2022 at Series C.

Alladapt Immunotherapeutics totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Menlo Park below to benchmark round size and investor mix.

Alladapt Immunotherapeutics Funding: $179M Raised, Series C

Alladapt Immunotherapeutics funding overview

Alladapt Immunotherapeutics at a glance

Frequently asked about Alladapt Immunotherapeutics funding

Companies related to Alladapt Immunotherapeutics (25)

Browse related funding lists (5)